Known so far: no new shares from the prospectus covers read · shelf room about $7.1M · not yet read: warrants, converts, options, ATM.
Shelf room
Room todayabout $7.1M, maybe lower
One third of float$7.1M ($21.3M float, Jun 30, 2025)
Sold off it, 12 monthsnothing
How this is worked out
Shelf room about $7.1M on the S-3 of Mar 29, 2024: the baby-shelf rule (public float under $75M) caps sales at one third of the $21.3M public float stated as of Jun 30, 2025, $7.1M, nothing sold off it in the last 12 months; 1 more sale off the shelf with no size read, so the room may be lower. Sources: S-3 Mar 29, 2024, effective May 10, 2024 · public float, as of Jun 30, 2025 · 424B5 Aug 17, 2026.
What could become new Dare Bioscience (DARE) shares, from its 10-Q, 10-K, S-1 or 424B filings.
Read so far: the cover share count (15.3M shares, +13% from 13.5M on Aug 13, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program.Read them on EDGAR: the latest 10-Q · S-1 registration filings.
Registrations and share actions on EDGAR (58 filings)
Registration statements, prospectuses, effectiveness notices, information statements and share sales, newest first. Showing the newest 15 of 58. Each links to the filing on EDGAR.
424B3Prospectus for shares being soldSize not read yet